Peptonic Medical Q2 FY26 operating loss widens to SEK 3.71 million; sales fall to SEK 2.36 million

PUBT · 2d ago
Peptonic Medical Q2 FY26 operating loss widens to SEK 3.71 million; sales fall to SEK 2.36 million
  • Peptonic Medical posted Q2 (April–June) net sales of SEK 2.36 million, down 51.96% year over year.
  • Operating loss widened to SEK 3.71 million from SEK 3.49 million a year earlier.
  • Gross profit fell to SEK 1.42 million; gross margin narrowed 37 percentage points to 60%.
  • Earnings per share improved to SEK -0.0002 from SEK -0.0004.
  • Shipped first delivery under its US partnership; warrants TO6 exercise raised about SEK 7.5 million before costs and set-offs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PEPTONIC Medical AB published the original content used to generate this news brief via Cision (Ref. ID: 20260818:BIT:9239:0) on August 19, 2026, and is solely responsible for the information contained therein.